Literature DB >> 12542484

Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count.

Massimo Breccia1, Ida Carmosino, Daniela Diverio, Silvia De Santis, Maria Stefania De Propris, Atelda Romano, Maria C Petti, Franco Mandelli, Francesco Lo-Coco.   

Abstract

Extramedullary relapse occurs infrequently in acute promyelocytic leukaemia (APL) but has been increasingly reported after the advent of all-trans retinoic acid (ATRA) treatment, probably as a consequence of improved patient survival. We describe our single centre experience of six APL patients who had disease localization in the central nervous system (CNS). In three patients, clinical symptoms (headache and/or nausea) that presented during follow-up led to the performance of a lumbar puncture and detection of overt CNS infiltration. Two of these patients had simultaneous haematological relapse and one was in molecular remission when CNS leukaemia was documented. One patient with no local symptoms showed CNS infiltration at the time of molecular relapse. Following the introduction of routine lumbar puncture, carried out after front-line induction in all newly diagnosed patients with white blood cell count (WBC) greater than 10 x 109/l, two additional patients in molecular remission with no local symptoms were found to have initial APL localization in the CNS. Presenting features included in 6/6 patients an elevated WBC count (> 10 x 109/l) and a predominance of the PML/RAR bcr3 type (5/6 patients) and of microgranular morphology (5/6 patients). Our findings highlight the importance of carrying out lumbar puncture in APL patients presenting with high-risk features.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542484     DOI: 10.1046/j.1365-2141.2003.04056.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Concurrent craniospinal radiotherapy and intrathecal chemotherapy in patient with acute promyelocytic leukemia second relapsed in central nervous system (CNS) following allogeneic stem cell transplantation.

Authors:  Hea Yong Lee; Kwang Min Kim; Myoung-Hee Kang; Jung Hun Kang; Ki-Mun Kang; Gyeong-Won Lee
Journal:  J Neurooncol       Date:  2006-05-23       Impact factor: 4.130

2.  Molecular or cytogenetic monitoring and preemptive therapy for central nervous system relapse of acute promyelocytic leukemia.

Authors:  Sumimasa Nagai; Yasuhito Nannya; Shunya Arai; Yumiko Yoshiki; Tsuyoshi Takahashi; Mineo Kurokawa
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

3.  Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia.

Authors:  N Colovic; D Tomin; A Vidovic; N Tosic; H D Atkinson; Milica D Colovic
Journal:  Med Oncol       Date:  2011-02-05       Impact factor: 3.064

4.  Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.

Authors:  Pau Montesinos; Joaquín Díaz-Mediavilla; Guillermo Debén; Virginia Prates; Mar Tormo; Vicente Rubio; Inmaculada Pérez; Isolda Fernández; Maricruz Viguria; Chelo Rayón; José González; Javier de la Serna; Jordi Esteve; Juan M Bergua; Concha Rivas; Marcos González; Jose D González; Silvia Negri; Salut Brunet; Bob Lowenberg; Miguel A Sanz
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

5.  Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.

Authors:  Arturo Vega-Ruiz; Stefan Faderl; Zeev Estrov; Sherry Pierce; Jorge Cortes; Hagop Kantarjian; Farhad Ravandi
Journal:  Int J Hematol       Date:  2009-04-02       Impact factor: 2.490

Review 6.  What is the standard regimen for patients with acute promyelocytic leukemia?

Authors:  Francesco Lo-Coco; Laura Cicconi
Journal:  Curr Hematol Malig Rep       Date:  2014-06       Impact factor: 3.952

7.  Emerging new approaches for the treatment of acute promyelocytic leukemia.

Authors:  Jae Park; Joseph G Jurcic; Todd Rosenblat; Martin S Tallman
Journal:  Ther Adv Hematol       Date:  2011-10

8.  Extramedullary relapse in lumbar spine of patient with acute promyelocytic leukemia after remission for 16 years: a case report and literature review.

Authors:  Zhengmei He; Shandong Tao; Yuan Deng; Yue Chen; Lixiao Song; Banghe Ding; Kankan Chen; Liang Yu; Chunling Wang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 9.  Current first- and second-line treatment options in acute promyelocytic leukemia.

Authors:  Fulvio Massaro; Matteo Molica; Massimo Breccia
Journal:  Int J Hematol Oncol       Date:  2017-02-02

Review 10.  Contemporary treatment of APL.

Authors:  Elizabeth H Cull; Jessica K Altman
Journal:  Curr Hematol Malig Rep       Date:  2014-06       Impact factor: 3.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.